Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



Adavosertib in Treating Patients with SETD2-Deficient Locally Advanced or Metastatic Solid Tumors

This phase II trial studies how well adavosertib works in treating patients with SETD2-deficient solid tumors that have spread to other places in the body. Adavosertib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.
Not Available
II
Rathmell, Kim
NCT03284385
VICCURO18153

To learn more about any of our clinical
trials, call 1-800-811-8480 or complete
the online Self-Referral Form here: